R&D, Pharmacovigilance & Regulatory Affairs_uk

R&D, Pharmacovilance & Regulatory Affairs

Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

  • R&D, Pharmacovilance & Regulatory Affairs

    Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

Title Sort ascending Location Date Req ID
Reset
Clinical Program Leader
Clinical Program Leader Europe - Remote, IT 2 Feb 2026 5902
Europe - Remote, IT 2 Feb 2026 5902
Clinical Trial Documentation & Records Management Lead Parma, IT 17 Jan 2026 6428
INTERN - Patient Engagement
INTERN - Patient Engagement PARMA, IT 29 Jan 2026 5993
PARMA, IT 29 Jan 2026 5993
Intern, Regulatory Affairs, Global Rare Diseases - Summer 2026 Cary, NC, US 16 Jan 2026 6413
Manager, CMC Regulatory Affairs, Global Rare Diseases Europe, IT 10 Feb 2026 6592
Pharmazeut (all genders) im Praktikum für 2026 / 2027 Hamburg, DE 6 Feb 2026 351
R&D Manufacturing & Technology Transfer Manager Parma, IT 20 Jan 2026 6501
Senior Clinical Research Physician Non-Obstructive Respiratory Diseases UK, GB 16 Jan 2026 5448
Senior Director, Clinical Biometrics & Analytics Parma, IT 12 Feb 2026 6387
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT 18 Jan 2026 6111
Senior Global Project Manager
Senior Global Project Manager Cary, USA, US 5 Feb 2026 6561
Cary, USA, US 5 Feb 2026 6561
Senior Global Project Manager
Senior Global Project Manager Italy, IT 30 Jan 2026 6546
Italy, IT 30 Jan 2026 6546
Sr. Director, Clinical Programs, Global Rare Diseases Boston, MA, US 24 Jan 2026 6205
Sr. Manager, CMC Regulatory Affairs
Sr. Manager, CMC Regulatory Affairs United States, US 22 Jan 2026 6204
United States, US 22 Jan 2026 6204